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Fenugreek (Trigonella foenum-graecum L. seed) is a
food with traditional medicinal use in diabetes.
Beneficial effects have been demonstrated in dia-
betic animals and both insulin-dependent and
non-insulin-dependent diabetic subjects. Effects
of a lipid extract A, crude ethanolic extract B, fur-
ther sub-fractions of B (saponin-free C, saponin D
and sapogenin E) and a gum fibre fraction F on
intestinal sodium-dependent glucose uptake were
investigated in vitro using rabbit intestinal brush
border membrane vesicles. All fractions except A
inhibited glucose-uptake at 0.33 and/or 3.3mg/mL
(p < 0.001). Greatest inhibition was observed with
fractions D and E. Diosgenin and trigonelline
(compounds reported in fenugreek) also inhibit-
ed glucose-uptake (IC50 values approximately 3mg/
ml, equivalent to 8mM and 19mM respectively)
but did not account for the activity of the
crude extracts. Fenugreek extracts had no effect
on basal levels of glycogen phosphorylase a
(HGPa) activity in rat hepatocyte suspensions.
However fractions C and E caused a marginal
but statistically significant inhibition (18.9 and
15.1% respectively, p < 0.05) of glucagon induction
of this enzyme suggesting a glucagon-antagonist
effect. Diosgenin (1.65mg/ml; 4mM) inhibited
glucagon-induced HGPa activity by 20% (p < 0.05),
and was more effective than trigonelline (non
significant inhibition of 9.4% at 1.65mg/ml,
10mM).
Keywords: Fenugreek; Trigonella; SGLT-1; BBMV; Glycogen
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INTRODUCTION
Diabetes mellitus affects 3-5% of people living
in Western countries and is a heterogeneous dis-
order with varying prevalence among different
ethnic groups. [1] Based on the emerging rela-
tionship between hyperglycaemia and degree of
glycaemic control on one side and the develop-
ment of microvascular and macrovascular com-
plications on the other,[2,3] there is a growing
interest in the inclusion of beneficial food sub-
stances in the diet to assist the control of
glucose levels.
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Fenugreek (Trigonella foenum-graecum L.) is an
annual plant from the family Papilionaceae-
Leguminosae, and is extensively cultivated as a
food crop in India, the Mediterranean region,
North Africa and Yemen. Main uses of the seeds
(often referred to as "fenugreek") are as a spice
and, when defatted, as a flour. Fenugreek has
also been credited with many medicinal prop-
erties (reviewed by AL-Habori and Raman,
1998). [4] In particular, anti-diabetic and hypocho-
lesterolaemic effects have been demonstrated in
diabetic animals and both insulin-dependent
and non-insulin-dependent (Type I and Type II)
diabetes mellitus. [4,5,6,7] For example, [61 con-
sumption of 15g of ground fenugreek 15 min-
utes before a standardised meal, reduced the
postprandial elevation of plasma glucose by an
average of 20% (p < 0.05) in 17 out of 21 Type II
patients. In a group of 11 Type I patients, con-
sumption of 100 g of fenugreek daily for 10 days
resulted in a lowering of fasting blood glucose
from 15.1 to 10.9mM, a 20% decrease in the area
under the glucose tolerance curve and a 54% fall
in 24-hour urinary sugar excretion. [7]
The anti-diabetic activity of fenugreek is pri-
marily associated with the defatted fraction of
the seeds,[8,9,1] and can be largely attributed to
their saponin and high fibre content but not to
the major alkaloid trigonelline. [5,6,111 Suggested
mechanisms for fenugreek’s anti-diabetic effects
include delayed gastric emptying and interfer-
ence with glucose absorption due to high fibre
content,[5,6,11] inhibition of pancreatic c-amylase
and intestinal disaccharidase enzymes,[2,3] or
the presence of an orally active principle capable
of inducing hypoglycaemia [14,15] or enhanced
plasma insulin levels. [16,17] The compound 4-
hydroxyisoleucine, which represents up to 80%
of free amino acids in fenugreek seeds, was
found to possess insulin-secretagogue properties
both in pancreatic islets in vitro and in rats and
dogs in vivo. [18’19]
In the light of the reported beneficial role of
fenugreek in the management of diabetes, and
its complex chemical profile, the aim of this
study was to investigate further the possible
mechanisms and target sites through which
fenugreek may act, by making use of in vitro
models. We have prepared a range of fractions
to investigate the role of different fenugreek
constituents in its anti-diabetic activity. Most
studies [41 have employed the defatted seeds.
However, we have also investigated the activity
of the lipid fraction which would normally be
discarded. The defatted ethanol extract (used in
many studies) would be expected to contain
saponins and other polar materials. We have
used n-butanol to separate the saponins from
water-soluble constituents of fenugreek. Since
saponins are likely to undergo hydrolysis in the
gastrointestinal tract an aglycone (sapogenin)
extract was prepared. Finally we have also test-
ed the effect of trigonelline and diosgenin (a
sapogenin) two well known compounds derived
from fenugreek.
The effects of the fenugreek fractions on
intestinal glucose uptake was investigated using
isolated intestinal brush border membrane
vesicles (BBMVs) prepared from the apical
membrane microvilli of rabbit intestinal entero-
cytes [20’21] and effects on liver glycogen degra-
dation examined using isolated rat hepatocyte
suspensions. A polysaccharide gum fibre frac-
tion was tested in the intestinal model alone
since intact polysaccharides would not be ex-
pected to reach the liver.
There is evidence from rat models that the
expression of the sodium-dependent glucose
transporter (SGLT-1) and a sodium-independent
transporter GLUT-2 is raised in the diabetic
state, thus increasing the likelihood of hypergly-
caemia following a meal. [22’23’24] The major com-
ponent of glucose transport in rat isolated
enterocytes was found to be due to SGLT-1 [25]
which can be blocked by the plant-derived gly-
coside phloridzin (phlorizin). [261 BBMV comprise
spherical vesicles in which SGLT-1 is expressed
in the membrane, the outer surface representing
the intestinal lumen and the core of the vesicle
the intestinal cell. The advantage of using BBMV
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in such studies is that SGLT-l-mediated glucose
transport can be studied uncomplicated by
interference from GLUT-2 transporters [27] or
cytoplasmic glucose metabolism.
Isolated hepatocyte suspensions provide a
good model for studying insulin-like or
glucagon-antagonistic activity. One enzyme that
may be studied is hepatic glycogen phosphory-
lase a (HGPa), which causes the degradation of
glycogen to glucose-l-phosphate. However, in
vitro, the activity of the enzyme is studied using
the reverse reaction. Insulin has been shown to
reduce the activity of this enzyme in the absence
of glucagon as well as counteracting the
glucagon stimulation of HGPa. [281
MATERIALS AND METHODS
Materials
All chemicals were obtained from Sigma Chemi-
cal Company (Poole, Dorset, UK). Commercial
fenugreek seed was purchased from an Indian
supermarket in North London. A voucher speci-
men (number Tr 91Kg) has been deposited in
the Pharmacognosy Research Laboratories,
Pharmacy Department, Kings College London.
Extraction and Phytochemical Work
Preparation ofExtracts
Fenugreek seed (lkg) was ground in a Maig
grinder to pass through a 0.Smm mesh sieve
and continuously extracted (Soxhlet apparatus)
with light petroleum (40/60) for 16 hours. The
extract was dried by rotary evaporation under
vacuum to yield an oil fraction (A; 45g). The
defatted fenugreek seed powder (895g) was
dried at room temperature and continuously
extracted with absolute ethanol for 24 hours.
Drying as before yielded the crude ethanolic
extract (B; 65g). A portion of B was re-dissolved
in water and further extracted by n-butanol
(500ml) in a separating funnel. A saponin extract
(C; 16.9g) was obtained by evaporating the n-
butanol layer, leaving the water layer containing
saponin-free extract (D; 13.7g on freeze drying).
An aglycone extract (E; 6.75g) was obtained by
hydrolysis of the saponin extract (C; 9.2g)
by refluxing it with HaSO4 (10%, 20ml) for 30
minutes and then extracting it with equal
volume of chloroform, which was later dried
under vacuum.
Gum fibre was extracted according to a previ-
ously reported method. [5] Defatted seed powder
(1 g) was extracted with acetic acid (5% aqueous,
100ml) by continual stirring at room tem-
perature for 30 minutes. The mixture was
centrifuged (30 minutes; 20,000rpm) and the
supernatant was recovered. The above acetic
acid extraction of the sediment and centrifuga-
tion was repeated 3-times. Supernatants were
pooled together and gum fibre precipitated by
addition of absolute ethanol to 50% v/v with
continuous stirring. The suspension was cen-
trifuged (10,000rpm; 15 minutes). The super-
natant was decanted and the precipitate washed
with absolute ethanol and acetone. The hair-like
precipitate was collected by filtration (F; 90mg).
Preparation ofFractionsfor Bioassay
Due to their poor water-solubility, the fractions
were solublized in 0.3%v/v Tween-80 for test-
ing. The latter solution was used as the control
in these experiments. The fibre fraction pro-
duced a thick gel on dissolving in 0.3% Tween
80 and was only tested at a concentration of
0.33mg/ml.
Flash Chromatography
The aglycone fraction (E; 1.09 g) was subjected to
silica gel flash chromatography (Kieselgel 60,
40-63m; 40g), eluting successively with 200ml
volumes of petroleum ether, petroleum ether-
chloroform (1 1), chloroform, chloroform-
methanol (19:1, 9:1, 5:1, 4:1, and 1:1) and
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methanol. Eluate was collected as 100ml frac-
tions, which were concentrated and compared
with parent extract (E) using silica-gel thin-layer
chromatography (TLC; solvent: chloroform:
methanol, 19:1, plate dried and transferred to a
second tank containing chloroform: methanol:
water, 65:35:10). TLC zones were detected
using anisaldehyde spray reagent (anisalde-
hyde:methanol:sulphuric acid:acetic acid, 0.5:
85:10:5) followed by heating at 105C. Fractions
of similar chemical constituents were pooled
together. The major fraction (G; 0.83g) eluted
with chloroform.
Glucose Content ofExtracts
The presence of sugars (glucose, galactose and
fructose) in the extracts was determined qualita-
tively by TLC and quantitatively by high perfor-
mance liquid chromatography (HPLC).
TLC system: Silica gel G, developed with ethyl-
acetate/acetic acid/methanol/H20 (60:15:15:10);
detection with anisaldehyde spray reagent as
described above.
HPLC system: Apex NH2 silica column (5Ix;
15cm), acetonitrile/H20 (80:20) mobile phase;
refractive index detection; internal standard
maltose.
Intestinal Glucose Uptake Experiments
Preparation ofRabbit Intestine
The small intestine of a New-Zealand White rab-
bit (killed by administration of sodium pentobar-
bitone) was dissected from the pyloric sphincter
to the ileo-caecal junction and put into ice-cold
KC1 solution (154mM). The remaining mesentery
and fat were thoroughly removed, the intestine
transferred to fresh ice-cold KC1 solution and the
contents gently squeezed out. The small intestine
was cut longitudinally and washed thoroughly
in KC1 solution. It was then blotted dry with
paper tissue, snap frozen in a plastic bag in liq-
uid nitrogen, and stored at -70C.
Preparation ofBBMV
BBMV were prepared from the tips of the
microvilli of rabbit cleaned small intestine using
the divalent-cation precipitation method [21 as
modified by Kessler et al. (1978). [21] Frozen small
intestine was thawed in Buffer 1 (200ml; D-man-
nitol 10mM, HEPES 2mM, Tris to pH 7.4). Epithe-
lium was separated from the underlying mucosa
by mechanical vibration on a VIBRO mixer at
maximum speed (lmin), cooling in ice (lmin),
followed by further vibration (30s). The solution
was filtered under vacuum through a Buchner
funnel, without filter paper, to remove muscle
debris. The filtrate was made up to volume
(300ml) with Buffer 1 and solid MgC12 (0.61g)
added. After stirring (0C, 20min), the suspension
was centrifuged (3015g, 4C, 15min). The resul-
tant supernatant was centrifuged (34858 g, 4C, 30
min) and the supernatant discarded. The pellet
was resuspended in Buffer 2 (8ml; D-mannitol
100mM, MgSO4 0.1mM, HEPES 2mM, Tris to pH
7.4). The resuspended pellet was centrifuged
(34858g, 4C, 40min) and the supernatant dis-
carded. The resultant washed pellet was resus-
pended in 3 times the pelleted volume in Buffer 3
(mannito1300mM, MgSO4 0.1mM, HEPES 10mM,
Tris to pH 7.4). The suspension was passed 5
times through a 25 gauge needle, aliquoted in 0.26
ml volumes and snap frozen in liquid nitrogen.
Prior to use, each aliquot (0.26ml) of BBMV was
diluted with Buffer 3 (0.44ml). This final suspen-
sion will be referred to as the BBMV suspension.
BBMV Protein Content
Protein content of the BBMV suspension (dilut-
ed 1:10, 1:50 and 1:100 in water) was assayed
against bovine serum albumin using Coomassie
blue as per the Bradford method. [291
Glucose Uptake Studies
Glucose uptake was determined by the rapid-
filtration method of Hopfer et a/.[3] BBMV
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suspension (20txl) was incubated at 25C with
radio-labelled D-glucose in buffer (20 1; glucose
0.2mM, NaSCN 200mM, D-mannitol 200mM,
HEPES 20mM, Tris to pH 7.4, containing 3H-D-
glucose 0.3MBq per ml) and either test (extract)
dissolved in 0.3% Tween 80, 0.3% Tween 80 solu-
tion, or water (20txl). Reaction was initiated by
addition of BBMV suspension, and terminated at
the required time by addition of ice-cold stop-
wash buffer (lml; NaC1 200mM, phlorizin
250 IxM, 10mM HEPES, Tris to pH 7.4). The solu-
tion was filtered under vacuum through a pre-
wetted cellulose acetate/nitrate filter (0.45bm;
Millipore). The sample tube was rinsed with stop-
wash buffer (2 l ml) which was also passed
through the filter. The filter paper was transferred
to a scintillation vial containing Ready-Protein
scintillant (Beckman, Ireland). Radioactivity was
counted for 300s in a scintillation counter (LKB
Wallac 1209 Rackbeta). The time course of glu-
cose uptake was determined by terminating
incubations containing BBMV, glucose buffer and
water at short intervals over a one minute
period (Fig. 1). Some incubations were continued
to 5 minutes or 1 hour to ensure that equilibrium
was obtained (Fig. 1). Performance of vesicles
was routinely checked by ensuring that a satis-
factory peak to equilibrium ratio was obtained.
Time (seconds)
FIGURE 1 Typical glucose uptake profile into rabbit intesti-
nal brush border membrane vesicles (BBMV) in the absence
and presence of fenugreek extracts. Each point represents
the mean of 6 replicate incubations SEM for three separate
batches of BBMV.
For calculation of % inhibition, data from incuba-
tions terminated at 20 seconds (corresponding
to peak glucose uptake) were used. Data were
statistically analysed by one way ANOVA and
t-test. Glucose uptake was expressed (Tab. I) as
pmol glucose/mg protein + SEM of three dif-
ferent intestinal preparations (n=6 for each
preparation).
TABLE Glucose uptake into intestinal BBMVs in the presence of extracts of Fenugreek seeds
Test substance
Glucose uptake with test substance at:
3.3 mg/ml 0.33 mg/ml
(a) (b) (a) (b)
A-Oil fraction 442.5 17.6 (88%) ND ND
B Crude extract 362.8 6.9* (72%) 469.4 8.0* (94%)
C Saponin-free extract 183.2 8.9* (37%) 376.7 4.8* (75%)
D- Saponin extract 116.5 7.1" (23%) 392.9 2.6* (78%)
E- Aglycone extract 94.1 1.4" (19%) 348.8 12.2" (70%)
F- Fibre ND ND 307.1 6.3* (61%)
G- Main aglycone fraction 270.9 7.8* (54%) 376.3 11.0" (75%)
Diosgenin 274.8 10.1" (55%) 449.5 18.1 (90%)
Trigonelline 226.8 10.5" (45%) 307.1 8.4* (61%)
Data given as mean SEM of three separate BBMV preparations (n 6 for each preparation).
Control values 574.7 15.6 and 501.7 14.0 pmol glucose/mg protein for water and 0.3%
Tween 80 respectively. (a) Expressed as pmol glucose/mg protein; (b) expressed as a % of the
0.3% Tween 80 control; ND not determined. p < 0.001, with respect to Tween-80 (control);
not significantly different from water control.
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Isolated Hepatocyte Suspension
Experiments
Preparation ofHepatocyte Suspensions
Rat isolated hepatocyte suspensions were pre-
pared by a collagenase perfusion methodI311 and
adjusted to 3-5 106 cells per ml with Krebs’
medium. Aliquots were gassed with O2/CO2
(19" 1) for 15 seconds.
Test Incubations
Following a pre-incubation period of 30 minutes,
hepatocyte suspension (450bd) was transferred
to lml microcentrifuge tubes containing either
50 t,1 of test .sample, 50 bd vehicle control, or 25 bd
of glucagon (10 bM) and 25 bd of either test sample
or vehicle control. Once mixed the sample tubes
were incubated at 37C on a dry heating block for
4 minutes. The incubation was stopped by rapidly
freezing the tubes and storing them at -80C.
HGPa Assay
Crude HGPa was released from hepatocytes by
adding an equal volume (500bd) of ice-cold
MOPS buffer (100mM MOPS, 200mM NaF,
30mM NaEDTA, 10mM dithiothreitiol) to the
frozen sample which was then left to thaw on
ice. Hepatocytes were sonicated for 60 seconds
and the lysate vortexed and centrifuged (10 min;
2500 g; 4C).
To measure HGPa activity, 50 bl aliquots of the
supernatant were transferred to l ml microcen-
trifuge tubes containing 50 bd of radioactive assay
mixture (2% glycogen, ImM caffeine, 100mM glu-
cose-l-phosphate, 50nM 14C-glucose-l-phosphate
(specific activity 50GBq/mmole). This mixture
was vortexed and incubated in a water bath for 20
minutes at 37C and the reaction stopped by plac-
ing the sample tubes on an ice-bath. Aliquots of
reaction mixture (30 bd) were spotted onto 1cm2
filter paper pieces, washed 3 times with 66% (v/v)
ethanol in water, followed by a wash in acetone
for 1 minute and allowed to dry. The filter paper
pieces were transferred into scintillation vials,
5mL of scintillant fluid (Ecoscintillant A) added
and counted for radioactivity. The results were
statistically analysed by one way ANOVA and t-
test. HGPa activity (Tab. II) is expressed as nmol
of 14C-glucose-l-phosphate incorporated into
glycogen per mg of protein per minute + SEM of
three different hepatocyte preparations (n-3 for
each preparation).
TABLE II Effects of Fenugreek seeds extracts on hepatic glycogen phosphorylase a
activity
Hepatic glycogen phosphorylase a activity
+Glucagon -Glucagon
Test substance (a) (b) (a) (b)
Tween-80 25.8 _+ 1.1 (100%) 22.2 0.5 (100%)
A-Oil fraction 20.5 1.6 (80%) 26.9 2.3 (100%)
B Crude extract 21.7 2.1 (84%) 22.0 1.1 (99%)
C Saponin-free extract 20.6 __+ 0.2* (80%) 24.9 1.0 (112%)
D- Saponin extract 22.7 3.6 (88%) 23.5 1.0 (106%)
E- Aglycone extract 21.6 0.7* (84%) 25.2 1.9 (113%)
Diosgenin 20.4 0.3* (79%) 22.5 1.9 (101%)
Trigonelline 23.1 1.2 (89%) 23.1 __+ 0.8 (104%)
Data given as mean SEM of three separate hepatocyte preparations (n 3 for each
preparation). Fractions were tested at 3.3mg/ml in experiments without glucagon
and 1.65mg/ml with glucagon. (a) Results expressed as nmol glucose/mg protein/
min, (b) results expressed as a % of the Tween-80 control. p < 0.05, with respect to
Tween-80 (control).
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RESULTS AND DISCUSSION
Figure 1 shows typical profiles of glucose uptake
into BBMV obtained in control (0.3% Tween 80)
incubations and with 2 fenugreek fractions. All
extracts as well as diosgenin and trigonelline
were found to decrease the area under the glu-
cose uptake profile without altering the equilib-
rium glucose concentration at 3600s, indicating
that the integrity of the BBMV was maintained.
Tween 80 (0.3% v/v), was also found not to alter
the integrity of the vesicles compared to water
as shown by a non-significant difference in peak
glucose uptake (Tab. I) and no difference in the
equilibrium value at 3600s (data not shown).
Furthermore, we have found[321 that the addition
of phloridzin (an SGLT-1 inhibitor [261) decreases
peak glucose uptake in a dose-dependent man-
ner (ICs0 of 250 pM[321), thus validating the use
of this model for the.study of glucose uptake via
SGLT-1. Although GLUT-2 transporters are pri-
marily located in the basolateral membrane of
the enterocytes, their glucose-induced recruit-
ment to the brush border membrane has clearly
been demonstrated in perfused rat jejunum. [331
Indeed lower levels of GLUT-2 could be detect-
ed in rat BBMV even in the absence of glucose in
the perfusate. [33] Nevertheless, it seems unlikely
that GLUT-2 mediated transport occurs to any
significant extent in the BBMV model reported
in the present study since the uptake of labelled
glucose into the vesicles was unaffected by the
presence of up to 8mM fructose (data not
presented), whereas fructose and glucose are
known to exert mutual inhibition of uptake via
GLUT-2 transporters. [341
With the exception of the petroleum ether
extract (oil fraction, A) all the extracts signifi-
cantly reduced (p < 0.0001) glucose uptake at the
higher or both concentrations (Tab. I). Both lay-
ers derived from partitioning of the crude
ethanol extract (B) inhibited uptake, indicating
that both saponin (D) and non-saponin (C) con-
stituents may be involved. There was no loss of
activity on hydrolysing the saponins, indeed the
greatest inhibition of glucose uptake was seen in
the hydrolysed extract (E), believed to contain
sapogenins (aglycones). On further fractiona-
tion of (E) by flash chromatography the main
fraction G from this extract inhibited glucose
uptake by 46%; whereas the other subfractions
showed weaker inhibition (data not shown).
The observed inhibition of glucose uptake in the
aglycone fraction and its subfraction did not
appear to be due to diosgenin or trigonelline,
since no diosgenin or trigonelline could be
detected in these fractions by TLC. Furthermore,
diosgenin and trigonelline at 3.3mg/ml inhibit-
ed glucose uptake by only 45% and 55% as com-
pared to the 81% inhibition by 3.3mg/ml of
Extract (E). Of these two compounds diosgenin
(8mM) was more potent than trigonelline
(19.2mM). This suggests that diosgenin and
trigonelline are not solely responsible for the
effects seen with the crude extract. Further, in
comparison to phloridzin (IC50 0.3mM) [321 these
two compounds exhibited very weak inhibition
of this transporter.
Analysis of the sugar content of the extracts
showed the presence of small quantities of glu-
cose (0.016mM at 3.3mg/ml) and a negligible
amount of fructose in the crude extract (B), con-
siderably less in other extracts (< 0.01mM) and
none in the hydrolysed extract (E). This confirms
that the inhibition of radiolabelled glucose
uptake into BBMV by the fractions was not due
to competition by unlabelled glucose in the frac-
tions at the concentrations used.
The effect of the fenugreek extracts on the
activity of HGPa activity is shown in Table II.
None of the extracts (at 3.3mg/ml) inhibited
the enzyme in the absence of glucagon, sug-
gesting that an insulinomimetic effect was
not present. By contrast, in the presence of
glucagon, fenugreek extracts (at 1.65mg/ml)
inhibited the enhanced HPGa activity by
between 11-20% as compared to the control.
However, this was only statistically significant
(p<0.05) with the saponin-free C (18.9%)
and the sapogenin E (15.1%) fractions and
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diosgenin. The observed inhibition of HGPa
activity in the aglycone fraction is unlikely to
be due to diosgenin or trigonelline, since these
compounds could not be detected in this frac-
tion by silica-gel TLC. Nevertheless, diosgenin,
but not trigonelline, affected HGPa activity.
At 8mM diosgenin significantly inhibited
the enzyme activity by 20%. These results
suggest that some components of fenugreek
may be able to counteract the effects of the
hormone glucagon. Fenugreek methanol and
water extracts have also been shown to
reduce HGPa activity induced by adrenaline in
hepatocytes. [351
In conclusion, these results show that fenu-
greek seeds contain substances capable of
inhibiting the SGLT-1 mediated absorption
of glucose across the brush border membrane
of intestinal vesicles. The most active sub-
stance(s) with regard to inhibition of SGLT-1
seem to be non-lipid in nature, with the agly-
cone extract showing greatest activity. The
results may well be relevant to the in vivo situa-
tion in that concentrations of about 3mg/mL or
less of fenugreek extract are attainable in
the intestine, and the moieties reaching the
small intestine are more likely to be aglycones
than saponin glycosides (which would be
hydrolysed by stomach acids). The active com-
pound(s) are unlikely to be, but may be related
to, diosgenin or trigonelline, two compounds
previously associated with the medicinal prop-
erties of fenugreek. Further work to characterise
the mechanism (competitive or non-competi-
tive) by which SGLT-1 is inhibited by these
extracts could only be undertaken once pure
compounds are isolated from the active frac-
tions, as the use of mixtures may complicate the
results of such experiments.
Fenugreek seeds also seem to contain sub-
stances capable of affecting hepatic glycogen
metabolism by inhibiting glucagon-induced
HGPa activity in isolated liver hepatocytes.
This activity was associated with the aglycone
and saponin-free extracts. Although only a
weak effect was observed at a concentration of
1.65mg/mL, it is possible that the crude extracts
used contain low concentrations of the actual
active species, which if isolated would be effec-
tive at lower, and therefore more physiologically
relevant concentrations.
These potential intestinal and hepatic effects
of constituents of fenugreek seeds may explain
the anti-diabetic effects of fenugreek observed
by other researchers in various human and ani-
mal models. [41
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